78 related articles for article (PubMed ID: 33796273)
1. SMARCB1/INI1-deficient tumors of adulthood.
Parker NA; Al-Obaidi A; Deutsch JM
F1000Res; 2020; 9():662. PubMed ID: 33796273
[TBL] [Abstract][Full Text] [Related]
2. Genomic and Immunologic Characterization of INI1-Deficient Pediatric Cancers.
Forrest SJ; Al-Ibraheemi A; Doan D; Ward A; Clinton CM; Putra J; Pinches RS; Kadoch C; Chi SN; DuBois SG; Leavey PJ; LeBoeuf NR; Mullen E; Collins N; Church AJ; Janeway KA
Clin Cancer Res; 2020 Jun; 26(12):2882-2890. PubMed ID: 32122923
[TBL] [Abstract][Full Text] [Related]
3. SMARCB1/INI1-deficient intrathoracic neoplasm with rhabdoid/plasmacytoid cytomorphology in a patient with plasma cell myeloma: A case report.
Fujita K; Mizuguchi K; Mori T; Shimoda T; Sakano K; Shimaguchi C; Ito A; Yoshimura K; Sakaguchi M; Imi T; Ikeda H
Diagn Cytopathol; 2023 Oct; 51(10):E294-E300. PubMed ID: 37475580
[TBL] [Abstract][Full Text] [Related]
4. SMARCB1/INI1-deficient epithelioid and myxoid neoplasms in paratesticular region: Expanding the clinicopathologic and molecular spectrum.
Yin X; Yang X; Wang S; Zhou J; Zhao M
Ann Diagn Pathol; 2024 Feb; 68():152242. PubMed ID: 38039617
[TBL] [Abstract][Full Text] [Related]
5. Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults.
Thomas C; Wefers A; Bens S; Nemes K; Agaimy A; Oyen F; Vogelgesang S; Rodriguez FJ; Brett FM; McLendon R; Bodi I; Burel-Vandenbos F; Keyvani K; Tippelt S; Poulsen FR; Lipp ES; Giannini C; Reifenberger G; Kuchelmeister K; Pietsch T; Kordes U; Siebert R; Frühwald MC; Johann PD; Sill M; Kool M; von Deimling A; Paulus W; Hasselblatt M
Acta Neuropathol; 2020 Feb; 139(2):277-286. PubMed ID: 31732806
[TBL] [Abstract][Full Text] [Related]
6. Head and neck INI1-deficient carcinoma without primary: a case report.
Dubray-Vautrin A; Ghanem W; Bozec L; Gonin J; Choussy O
J Med Case Rep; 2023 Nov; 17(1):479. PubMed ID: 37974295
[TBL] [Abstract][Full Text] [Related]
7. SMARCB1/INI1-Deficient Poorly Differentiated Carcinoma of the Colon With Rhabdoid Features-A Rare Tumor With Serrated Phenotype: Case Report and Review of Literature.
Maurya S; Yadav S; Bhowmik S; Dhal J; Mehra L; Sharma R; Krishna A; Sharma A; Barwad A; Das P
Int J Surg Pathol; 2024 Feb; 32(1):187-195. PubMed ID: 37128676
[TBL] [Abstract][Full Text] [Related]
8. Case report metastatic SMARCB1 (INI1)-deficient gastric undifferentiated carcinoma in pleural effusion: A case report and literature review.
Zhong J; Xie Y; Niu Z; Xie M; Zhou D
Cytopathology; 2024 Jan; 35(1):153-156. PubMed ID: 37706577
[TBL] [Abstract][Full Text] [Related]
9. The rhabdoid variant of adrenocortical carcinoma-Report of three cases and literature review.
Ayyanar P; Sable MN; Adhya AK; Das MK; Kar M; Mishra P
Indian J Pathol Microbiol; 2023; 66(3):627-631. PubMed ID: 37530357
[TBL] [Abstract][Full Text] [Related]
10. Poorly Differentiated Chordoma of the Clivus With Loss of SMARCB1 Expression in a Pediatric Patient: A Case Report.
Yasue S; Ozeki M; Endo S; Kanayama T; Suzui N; Nakamura S; Kishimoto K; Kosaka Y; Miyazaki T; Demizu Y; Soejima T; Kawamura A; Ohnishi H
J Pediatr Hematol Oncol; 2022 Nov; 44(8):465-470. PubMed ID: 35091519
[TBL] [Abstract][Full Text] [Related]
11. SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors.
Liu NQ; Paassen I; Custers L; Zeller P; Teunissen H; Ayyildiz D; He J; Buhl JL; Hoving EW; van Oudenaarden A; de Wit E; Drost J
Nat Commun; 2023 Dec; 14(1):7762. PubMed ID: 38040699
[TBL] [Abstract][Full Text] [Related]
12. SMARCB1 (INI1)-deficient sinonasal carcinoma manifesting as oral lesions: A report of two cases.
Fuoco J; Huang M; Esfandiari N; MacMillan C; Ali A; Dave K; Freilich M; Magalhaes M
Head Neck; 2024 Mar; 46(3):E32-E39. PubMed ID: 38088461
[TBL] [Abstract][Full Text] [Related]
13. Elusive and Aggressive: Unraveling
Liu XL; Agostini-Vulaj D
Int J Surg Pathol; 2024 Feb; ():10668969241232699. PubMed ID: 38378024
[TBL] [Abstract][Full Text] [Related]
14. GATA3: Everyday Marker Supporting Neuroblastoma, but Pitfall With Rhabdoid Tumors.
Bobb BK; Mochel MC; Austin F; Smith SC
Int J Surg Pathol; 2024 May; 32(3):641-643. PubMed ID: 37394753
[No Abstract] [Full Text] [Related]
15. Underreporting
Wei CH; Wang E; Sadimin E; Rodriguez-Rodriguez L; Agulnik M; Yoon J; LoBello J; Szelinger S; Anderson C
Gynecol Oncol Rep; 2023 Dec; 50():101294. PubMed ID: 37876879
[TBL] [Abstract][Full Text] [Related]
16. The significance of SMARCB1 in the pathogenesis of renal cell carcinoma with rhabdoid features.
Wang YW; Song HL; Chiang CY; Song HF; Chang HY; Chu CA; Tuan YL; Tsai KH; Ou YC; Chow NH; Tsai YS
Transl Oncol; 2021 Oct; 14(10):101175. PubMed ID: 34243015
[TBL] [Abstract][Full Text] [Related]
17. SMARCB1/INI1-deficient primary lung carcinoma with hepatic metastasis.
Rickard JA; Burr ML; Williams B; Murugasu A; Fellowes A; John T; Christie M
Pathology; 2022 Oct; 54(6):817-820. PubMed ID: 35177248
[No Abstract] [Full Text] [Related]
18. [Research progresses of INI1-deficient tumors in children].
Zhang SH; Su Y
Zhonghua Er Ke Za Zhi; 2024 Jan; 62(1):82-86. PubMed ID: 38154984
[TBL] [Abstract][Full Text] [Related]
19. SMARCB1 (INI1) Deficient Tumours of the Uterine Cervix: Report of Two Cases, Including One Associated With an NTRK Fusion.
Razack R; Butt JL; Hostein I; Velasco V; Croce S; Olory C; Fu L; Foulkes WD; McCluggage WG
Int J Gynecol Pathol; 2024 Jan; ():. PubMed ID: 38289183
[TBL] [Abstract][Full Text] [Related]
20. Primary extrarenal rhabdoid tumour of the liver: a case report and literature review.
Meyers Michel; Demetter Pieter; De Roo An-Katrien; Pezzullo Martina; Jungels Christiane; Brichard Bénédicte; De Magnee Catherine; De Krijger Ronald R; Verset Gontran
Acta Gastroenterol Belg; 2023; 86(4):555-562. PubMed ID: 38240550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
